Theratechnologies Inc. (THTX) Financials

THTX Assets vs Liabilities

DateAssetsLiabilities
2024-02-29 72.0 million 96.6 million
2023-11-30 77.8 million 98.6 million
2023-08-31 56.7 million 98.4 million
2023-05-31 68.7 million 110.3 million

THTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-02-29 -1.7 million ?
2023-11-30 -5.6 million 418000
2023-08-31 5.3 million 519000
2023-05-31 -3.6 million 702000

THTX Net Income

No data available :(

THTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-02-29 38.4 million - -
2023-11-30 40.4 million - 994000
2023-08-31 22.9 million - 1.1 million
2023-05-31 25.4 million - 1.2 million

THTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-02-29 46.0 million
2023-11-30 34.4 million
2023-08-31 24.2 million
2023-05-31 24.2 million

THTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-02-29 - 3.7 million - -
2023-11-30 1.5 million 5.2 million 3.7 million 6.7 million
2023-08-31 15000 5.4 million 3.7 million 6.7 million
2023-05-31 81000 10.4 million 3.7 million 6.5 million

THTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-02-29 16.1 million 5.7 million
2023-11-30 23.5 million 5.1 million
2023-08-31 20.9 million 5.0 million
2023-05-31 17.5 million 4.9 million

THTX

Price: $1.28

52 week price:
0.88
4.32

Earnings Per Share: -0.91 USD

P/E Ratio: -1.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 5200

Market Capitalization: 60.1 million

Links: